BioVentures — Full Portfolio
3 tracked investments · listed companies and verified rows first
Profusa develops injectable hydrogel biosensors and AI-driven health platforms that enable real-time measurement of body chemistry from within tissue.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Francisco, US
Bill Fawcett(Co-founder)Ben Healy(CEO)Natalie Wisniewski(Executive Officer, Director)Qianye Karen Liu(Director)Ben Hwang(Executive Officer, Director)Thomas Gutshall(Director)
Board seatQianye Karen Liu· per SEC Form D · $17M raise · filed Jul 2015
Avirmax is a preclinical-stage biopharmaceutical company developing AAV-based genetic medicines to treat chronic and degenerative ocular diseases.
BiotechDeep TechMedical DevicesHayward, US
Yu Fang(Director of the Issuer)Qianye Karen Liu(Director of the Issuer)Haifeng Chen(Director and Treasurer of the Issuer)Shengjiang Liu(Executive Officer, Director)Nancy Chang(Director of the Issuer)
Board seatQianye Karen LiuYu Fang· per SEC Form D · $10M raise · filed Nov 2019
BiotechWeston, US
Simon Robson(Executive Officer, Director)
Board seatQianye Karen Liu· per SEC Form D · $3.8M raise · filed May 2020
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.